Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2024Stem Cell ResearchOpen Access

Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

QLQunjuan LeiWZWenyan ZhouLHLing Huang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lei et al. (2024) studied this question.

synapsesocial.com/papers/68e781eeb6db6435876f4ce4https://doi.org/10.1016/j.scr.2024.103357
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A2025
  2. 2Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication2024 · 1 citations
  3. 3Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation2024 · 1 citations
  4. 4Establishing a human-induced pluripotent stem cell line SMUSHi005-A from a patient with hypophosphatemic vitamin D-resistant rickets carrying the PHEX c.1586–1586+1 delAG mutation2024
  5. 5Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models2025